Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim to build $65m US research facility

Will add new R&D operations to its US headquarters in Connecticut

Boehringer Ingelheim is expanding its R&D operations in the US with a new research and development facility.

The $65m facility will be located at the company's US headquarters in Ridgefield, Connecticut and when completed will handle production of active pharmaceutical ingredients used in early development activities.

It brings the total of Boehringer's investment in the US this year to $350m, adding to spending on projects such as a $42m new drug safety assessment building in Ridgefield and a $50m high containment operations facility in Columbus, Ohio.

J Martin Carroll, president and CEO of the company's US operations, said: “These are exciting projects; ones that increase Boehringer Ingelheim's research and development capabilities and reinforce our commitment to growth and innovation in the US.”

“Through these investments we are improving our ability to research, develop and manufacture the medicines of tomorrow and in doing so fulfilling our promise to bring more health to patients and their families.”

15th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics